Dr. Razi Khan is a cardiologist at Royal Columbian Hospital. His specialty interests include percutaneous coronary intervention for coronary artery disease, patent foramen ovale (PFO) closure/atrial septal defect (ASD) closure, balloon aortic valvuloplasty, novel therapies for mitral regurgitation and endoymocardial biopsies.

Areas of expertise

  • Coronary artery disease
  • Patent foramen ovale
  • Atrial septal defects
  • Valvular heart disease
  • Heart failure
  • Cardiac arrhythmias

Department(s)

  • Cardiology

Location(s)

Formal education

  • MD – 2006 – McGill University
  • MSc – Epidemiology – 2014 – Harvard University (School of Public Health)
  • Interventional Cardiology Fellowship – 2012-2014 – Montreal Heart Institute
  • Internal Medicine/Cardiology – 2006-2012 – University of Western Ontario  

Publications

  • Khan R, Al-Hawwas M, Hatem R, Azzalini L, Fortier A, Joliecoeur EM, Tanguay JF, Lavoie-L'Allier P, Ly HQ. Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2016; 88:740-747.
    10.1002/ccd.26413
  • Khan R, Lopes R, Neely M, Alexander JH, Goodman SG. Characterizing and Predicting Bleeding Events Following an Acute Coronary Syndrome: Insights from the Apixiban for Prevention of Acute Ischemic Events (APPRAISE)-2 Trial. Heart. 2015;101:1475-84.
    10.1136/heartjnl-2014-307346
  • Khan R, Spagnoli V, Tardif JC, L'Allier PL Novel anti-inflammatory therapies for the treatment of atherosclerosis. Atherosclerosis. Jun 2015: 497-509.
    10.1016/j.atherosclerosis.2015.04.783

Research

Research interests include outcome based studies and clinical trials in post-ACS patients. 

  • Examining outcomes amongst NSTEMI patients receiving medical management (VIGOUR Registry)
  • Understanding the role of IL-B1 in atherosclerosis

Awards, honours, recognition and certification

  • FRCP(C) – 2013 – Cardiology
  • FRCP(C) – 2010 – Internal Medicine
  • Echocardiography – 2012 – Level II

Contact Information

Tel: 604-524-9571 
Fax: 604-524-5322 
Monday to Friday, 9:00 a.m. to 4:30 p.m.

Text Size
A
A